Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling-Reference-Cited by-同舟云学术

Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling

Published:2014-06-24 Issue:1 Volume:171 Page:97-107
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Johnston A.¹,Guzman A.M.¹,Swindell W.R.¹,Wang F.¹,Kang S.²,Gudjonsson J.E.¹

Affiliation:

1. Department of Dermatology; University of Michigan; Ann Arbor MI 48109 U.S.A

2. Department of Dermatology; Johns Hopkins Medicine; 1550 Orleans Street Baltimore MD U.S.A

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health

Dermatology Foundation

American Skin Association

Amgen

National Psoriasis Foundation

Babcock Foundation Endowment

Taubman Medical Research Institute

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12937/fullpdf

Reference42 articles.

1. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial;Moreland;Ann Intern Med,1999

2. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group;Targan;N Engl J Med,1997

3. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial;Mease;Lancet,2000

4. The impact of psoriasis on health care costs and patient work loss;Fowler;J Am Acad Dermatol,2008

5. Development, cytokine profile and function of human interleukin 17-producing helper T cells;Wilson;Nat Immunol,2007

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Interleukin-17 Receptor A Gene Variants on Asthma Susceptibility and Clinical Manifestations in Children and Adolescents;Children;2024-05-28

2. Ex vivo cell-based assay for assessment of response to TNF inhibitors in patients with rheumatic diseases;Rheumatology;2024-05-25

3. The Immunology of Psoriasis—Current Concepts in Pathogenesis;Clinical Reviews in Allergy & Immunology;2024-04-20

4. Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities;Expert Review of Clinical Pharmacology;2024-04-02

5. Deep analysis of skin molecular heterogeneities and their significance on the precise treatment of patients with psoriasis;Frontiers in Immunology;2024-03-01